Gifu University · University Hospital · 准教授

Research keywordsgastric cancer・metastatic colorectal cancer・pancreatic cancer・immune checkpoint therapy・phase two trials・cancer chemotherapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment.
• Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
• Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.
• Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept.

• Official profile